$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Nomograms for the Prediction of Pathologic Stage of Clinically Localized Prostate Cancer in Korean Men 원문보기

Journal of Korean medical science : JKMS, v.20 no.2 = no.102, 2005년, pp.262 - 266  

Song, Cheryn (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) ,  Kang, Taejin (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) ,  Ro, Jae Y. (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) ,  Lee, Moo-Song (Department of Preventive Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) ,  Kim, Choung-Soo (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) ,  Ahn, Hanjong (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.)

Abstract AI-Helper 아이콘AI-Helper

We analyzed the prostate cancer data of 317 Korean men with clinically localized prostate cancer who underwent radical prostatectomy at Asan Medical Center between June 1990 and November 2003 to construct nomograms predicting the pathologic stage of these tumors, and compared the outcome with preexi...

주제어

참고문헌 (16)

  1. 1 Partin AW Kattan MW Subong EN Walsh PC Wojno KJ Oesterling JE Scardino PT Pearson JD Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 1997 277 1445 1451 9145716 

  2. 2 Partin AW Yoo J Carter HB Pearson JD Chan DW Epstein JI Walsh PC The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 1993 150 110 114 7685418 

  3. 3 Ackerman DA Barry JM Wicklund RA Olson N Lowe BA Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy J Urol 1993 150 1845 1850 7693981 

  4. 4 Egawa S Suyama K Arai Y Matsumoto K Tsukayama C Kuwao S Baba S A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men Jpn J Clin Oncol 2001 31 74 81 11302346 

  5. 5 Badalament RA Miller MC Peller PA Young DC Bahn DK Kochie P O'Dowd GJ Veltri RW An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level J Urol 1996 156 1375 1380 8808875 

  6. 6 Rogers E Gurpinar T Dillioglugil O Kattan MW Goad JR Scardino PT Griffith DP The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer Br J Urol 1996 78 419 425 8881954 

  7. 7 Epstein JI Walsh PC Carmichael M Brendler CB Pathologic and clinical findings to predict tumor extent of nonpalpable (Stage T1c) prostate cancer JAMA 1994 271 368 374 7506797 

  8. 8 Narayan P Gajendran V Taylor SP Tewari A Presti JC Jr Leidich R Lo R Palmer K Shinohara K Spaulding JT The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer Urology 1995 46 205 212 7542823 

  9. 9 Egawa S Suyama K Matsumoto K Satoh T Uchida T Kuwao S Koshiba K Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men Urology 1998 52 433 440 9730456 

  10. 10 Blute ML Bergstralh EJ Partin AW Walsh PC Kattan MW Scardino PT Montie JE Pearson JD Slezak JM Zincke H Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer J Urol 2000 164 1591 1595 11025711 

  11. 11 Kattan MW Stapleton AM Wheeler TM Scardino PT Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma Cancer 1997 79 528 537 9028364 

  12. 12 Ku JH Ahn JO Lee CH Lee NK Park YH Byun SS Kwak C Lee SE Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity Urology 2002 60 475 479 12350489 

  13. 13 Paulson DF Impact of radical prostatectomy in the management of clinically localized disease J Urol 1994 152 1826 1830 7523729 

  14. 14 Stein A deKernion JB Smith RB Dorey F Patel H Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer J Urol 1992 147 942 946 1371565 

  15. 15 Puppo P Perachino M Clinical stage, prostate-specific antigen and Gleason grade to predict extracapsular disease or nodal metastasis in men with newly diagnosed, previously untreated prostate cancer Eur Urol 1997 32 273 279 9358212 

  16. 16 Veltri RW Miller MC Mangold LA O'Dowd GJ Epstein JI Partin AW Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge J Urol 2002 168 100 104 12050500 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로